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ERY PROTOCOLS FOLLOWING COLORECTAL SURGERY
Anshi A. Dattani*, Philip H. Pucher, Sam Coulson, Ann-Marie Howell,
Paul Ziprin, Alison Knaggs. St Mary's Hospital, Imperial College Healthcare
NHS Trust, London, UK.
Introduction: Epidural anaesthesia is a key component of enhanced re-
covery care following colorectal surgery. Implementation in published
literature is variable, with little UK-speciﬁc data. We report retrospective
data from an academic tertiary centre on the success and effectiveness of
epidurals over a three-year period.
Methods: All patients undergoing elective colorectal surgery were iden-
tiﬁed over a ﬁve-month period from January 2011. Following imple-
mentation of several process improvement measures, a second cohort was
assessed from July 2013. Epidural failure rates and incidence of epidural-
associated complications were recorded from patient records.
Results: A total of 72 patients were included. The epidural failure rate did
not improve between cohorts (45% vs. 55% pre and post-intervention)
despite measures to improve implementation. There was a higher rate of
conversion to patient-controlled analgesia following epidural failure
(15.7% vs. 47.4% pre and post-intervention), with the remainder converting
to oral analgesia. There was no statistically signiﬁcant difference between
post-operative pneumonia rate in patients with epidural failure vs. no
failure in 2013 [13.3% (2/15) vs. 11.8% (2/19) (p¼0.801)].
Conclusions: Epidural anaesthesia has a high failure rate. Failure is not
associated with increased post-operative pneumonia risk. Our study
concurs with recent international data suggesting limited effectiveness of
epidurals. A more selective use in high-risk patients may be considered in
future.
0656: A COMPARATIVE AUDIT OF OUTCOME AFTER LAPAROSCOPIC AND
OPEN COLECTOMY FOR COLITIS
Marina Diament 1, Janice Miller*,1, Fiona Leitch 2, James Mander 1. 1Western
General Hospital, Edinburgh, UK; 2Crosshouse Hospital, Kilmarnock, UK.
Introduction: To compare the outcome of laparoscopic-assisted and open
colectomy in patients with inﬂammatory bowel disease (IBD) in a
specialist colorectal unit.
Methods: All patients undergoing colectomy for IBD between 2009 and
2012 were identiﬁed from a prospectively maintained electronic database.
Length of stay, mortality and morbidity including ileus, infection, bowel
obstruction, respiratory failure and venous thromboembolism were
compared.
Results: 80 patients underwent colectomy from 2009 to 2012, 48 as
emergencies. Hospital stay was 5 days shorter in the laparoscopic group.
There was 1 death after open operation. The overall morbidity was 69% in
the open and 44% in the laparoscopic group. Wound infection and ileus
were the commonest complications with both signiﬁcantly lower in the
laparoscopic assisted group, p¼0.007 and p¼0.048 respectively.
Conclusions: Laparoscopic colorectal resection is increasingly employed
across the whole spectrum of coloproctology. This retrospective audit of an
unselected cohort of IBD patients undergoing colectomy laparoscopic
operations had a lower morbidity, lower mortality and shorter hospital
stay. Laparoscopic colectomy for elective and emergency presentations of
IBD is feasible and promising however further prospective study including
detailed aspects of case selection for laparoscopic resection would be
valuable before advocating a policy of laparoscopic resection for all
patients.
0660: SURVIVAL OF PATIENTS WITH ISOLATED PERITONEAL CARCINO-
MATOSIS FROM COLORECTAL CANCER: 23 YEARS EXPERIENCE USING
CONVENTIONAL TREATMENT
Lewis Taylor*, Umar Shariff, Alex Coupland, Haney Youssef, John Glaholm.
Good Hope Hospital, Sutton Coldﬁeld, Birmingham, UK.
Introduction: Peritoneal metastasis (PM-CRC) the absence of distant
metastases occurs in 3-10% of colorectal cancer cases. Survival rates are
poor with conventional treatments, leading to more radical strategies
incorporating cytoreductive surgery (CRS) and Heated intraperitoneal
chemotherapy (HIPEC). This study aimed to investigate survival of patients
with isolated PM-CRC prior to introduction of CRS/HIPEC.
Methods: Data on demographics, treatments and survival for patients in
our hospital with PM-CRC (synchronous/metachronous) were collectedretrospectively (1989-2012). Patients with other distant metastases were
excluded.
Results: Of 40 patients with PM-CRC; complete data was available for 36.
Median age 65 years (33-80 years); M(56%):F(44%). 24/36(66.7%) under-
went surgical resection plus post-operative chemotherapy, 9/36(25%) had
chemotherapy only, 3/36(8.3%) had surgical resection only. Medial survival
following surgery plus chemotherapy: 23 months, chemotherapy only: 6
months, surgery only: 7.5 months. Kaplan-Meier predicted overall 1,2,3
and 5 year survival: 66.7%, 37.0%, 18.5% and 3.7% respectively. Overall
median survival: 19.5 months (0-79 months).
Conclusions: PM-CRC survival is poor using conventional treatments.
Several published series using CRS/HIPEC have reported better outcomes
using this radical treatment strategy for selected patients. This data pro-
vides a crucial baseline for comparison of survival of patient with PM-CRC
prior to the introduction of CRS/HIPEC in our unit.
0666: ENDOSCOPIC TATTOOING OF COLORECTAL CANCERS AND RESEC-
TION MARGINS
Rebecca Lisseter*, Claire Livsey, Nelson Wong, Peter Coyne, Ben Grifﬁths.
Royal Victoria Inﬁrmary, Newcastle-upon-Tyne, UK.
Introduction: To assess tattooing of colorectal cancer and resection
margins.
Methods: Surgically resected colorectal carcinomas from June 2012 to
August 2013were included. Histology reports were examined for resection
margins.
Results: 52 patients were included (32 male, 20 female, aged 45-88 years).
37 (71%) had tumour in the left colon and 16 (29%) were tattooed. In tat-
tooed tumours 37.5% of resection margins were more than 5cm (range 3.2-
90mm, mean 38mm, median 27mm). In non-tattooed tumours 23.8% of
resection margins were more than 5cm (range 4-300mm, mean 40mm,
median 20mm, P ¼ 0.19). 15 (12%) had tumour in the right colon and 11
(74%) were tattooed. In tattooed tumours 72.7% of resection margins were
more than 5cm (range 30-118mm, mean 64mm, median 50mm). In non-
tattooed tumours 75% of resection margins were more than 5cm (range
30-65mm, mean 55mm, median 57mm, P ¼ 0.46).
Conclusions: For left sided lesions, the percentage of resections with more
than 5cm clearance was higher in tattooed lesions. Although not statisti-
cally signiﬁcant, this is likely due to sample size. For right sided lesions the
resectionmargins were very similar. More consistent tattooing of left sided
colonic lesions will aid surgical resection with good margins.
0693: EROSION AFTER LAPAROSCOPIC VENTRAL MESH RECTOPEXY
Collins Ekere*,2, Krishnan Subramanian 2, Michael Lamparelli 2,
Andrew Clarke 1. 1Poole Hospital, Poole, UK; 2Dorset County Hospital,
Dorchester, UK.
Introduction: Erosion is a major complication after Laparoscopic ventral
mesh rectopexy (LVMR) and documented risk factors include vaginal hys-
terectomy (Tan-Kim et al. 2011), synthetic mesh (Wahed et al. 2012) and
intraoperativeperineal perforation (VanGeluweet al. 2013). Herewe report
our experience of erosion after LVMRand suggest possible causative factors.
Methods: We analysed our prospectively collected database of LVMR from
2007 to 2013, identifying patients that presented with erosion after LVMR
and reviewing their records.
Results: Between January 2007 and July 2013, we performed 309 cases. Of
these, 304 (98%) had primary LVMRand5 (2%) had a redo-LVMR. Therewere
8 (2.6%) male patients aged between 16 and 70 years (median 37years). The
female patients were aged between 23 and 99 years (median 67years). Of
our 309 cases, 6 (1.9%) presented with erosion, 5 eroded into vaginal vault
and 1 into rectum. Findings ofmesh and suture erosionwasmade in 3 (50%),
suture erosion in 1 (17%) andmesh erosion in 2 (33%). All had primary LVMR,
were female and aged between 35 to 75 years (Median 60 years).
Conclusions: Findings of erosion site containing thenon-absorbable suture
in 67% of cases and erosion mainly into vaginal vault (proximal suture site)
suggest that suture erosionmay contribute to cases of erosions after LVMR.
0695: NURSE TRIAGED STRAIGHT TO TEST LOWER GI ENDOSCOPY: THE
WHITTINGTON EXPERIENCE
Ankur Thapar 1,2,4, Simon Rodney 1,2,4, Danya Haboubi*,1,2,4,
Ayo Oshowo1,2,4, Chetan Bhan 1,2,4, Johnathan Wilson 1,2,4,
Maria Walshe 1,2,4, James Haddow3,2,4, Hasan Mukhtar 1,2,4. 1Whittington
Hospital, London, UK; 2Imperial College, London, UK; 3National Centre for
of Surgery 12 (2014) S13eS117 S31Bowel Research and Surgical Innovation, London, UK; 4University College,
London, UK.
Introduction: In 2011 patients referred with suspected colorectal cancer
at our institution waited a median of 36 days (IQR 28-46) for a decision to
treat. We aimed to reduce this waiting time.
Methods: Quality improvement methodology was employed to change
our existing clinic-ﬁrst service to a straight-to-test service. Our nurse-led
telephone triage service conﬁrmed symptoms and assessed ﬁtness for
colonoscopy, with higher-risk patients defaulting to ﬂexible sigmoidos-
copy or clinic.
Results: 438 patients were referred between 1/10/2012 and 1/10/2013. 217
went straight to colonoscopy and 136 to ﬂexible sigmoidoscopy, 46went to
clinic, 31 patients DNA'd and data was missing for 8 patients. Diagnoses
were colorectal cancer (14), non-colorectal cancers (4), normal (111) and
benign conditions (224). Median time to decision to treat was 25 days (IQR
20-34), a signiﬁcant reduction (p¼0.01). 41/66 (62%) of patients with a
normal colonoscopy were discharged directly from endoscopy.
Conclusions: The new straight to endoscopy pathway was associated with
an average reduction of 11 days in making a decision to treat. Appoint-
ments were saved in 88% of new patients and in 62% of thosewith a normal
colonoscopy.
0702: RE-ADMISSION FOLLOWING APPENDICECTOMY: THE ROLE OF
MISDIAGNOSIS
Ben Rymer*, Mark Watson. Darent Valley Hospital, Dartford, UK.
Introduction: To investigate the cause for a higher-than-peer readmission
rate following appendicectomy at a district general hospital.
Methods: CHKS database was used to identify all patients re-admitted
following appendicectomy within 30 days between April and November
2013. Data were gathered from CHKS database, discharge summaries and
case notes. Initial appendix pathology was reviewed.
Results: Between April and November 2013, 143 patients underwent ap-
pendicectomy with 13.2% (n¼19) readmitted within 30 days. This
compared with 7.9% in the peer cohort. Twelve patients had acute
appendiceal pathology, conﬁrmed by macroscopic appearance, histology
or radiological ﬁndings. All twelve had raised inﬂammatory markers on
admission. The main reasons for readmission in this group were wound
infection (n¼4) or post-op pain (n¼3). In ﬁve cases, no acute pathology
was found on histology. Of these, 80% had normal inﬂammatory markers
on admission. Related readmission in this group was due to post-op pain
(n¼2) or wound infection (n¼1).
Conclusions: A signiﬁcant number of patients (26%) readmitted following
appendicectomy had no acute pathology at initial operation. Recognised
post-operative complications led to these patients being readmitted.
Higher pre-operative diagnostic certainty would reduce unnecessary ap-
pendectomies and subsequently reduce readmissions. Inﬂammatory
markers on admission were predictive of ﬁnal diagnosis in this cohort.
0724: DEFUNCTIONING LOOP ILEOSTOMY IN RECTAL CANCER SURGERY
e HELP OR HINDRANCE?
Olga Rutka*, Meera Ramcharn, Gethin Williams, Keshav Swarnkar. Royal
Gwent Hospital, Newport, UK.
Introduction: To analyse incidence of ileostomy formation during anterior
resection, outcomes of these operations as well as to audit the rate of
reversal of loop ileostomies.
Methods: A prospective database of all patients undergoing elective
anterior resection for rectal cancer from January 2007 to December 2011
was interrogated. Outcome measures were: use of neoadjuvant therapy,
length of hospital stay (LOS), complications, anastomotic leak, reversal rate
and length of follow up.
Results: 131 patients underwent anterior resection. Fifty ﬁve patients
(42%) had a loop ileostomy fashioned, of these 55 patients 65% (n¼36) had
neoadjuvant therapy. Mean LOS for a patient with loop ileostomy was 13
days and for those without 12 days. The morbidity rate for patients with
loop ileostomy was higher than in those without (24% vs. 19%). There was
no signiﬁcant difference in an anastomotic leak between groups (7.3% vs.
6.6%). There was one case of 30 day mortality in group without ileostomy.
Out of 55 fashioned ileostomies only 69% (n¼38) have been reversed.
Conclusions: Most loop ileostomies are fashioned in patients that have
undergone neoadjuvant therapy. Vast numbers of loop ileostomies (31%)
Abstracts / International Journalare not being reversed. It is still not clear when to omit loop ileostomy in
rectal resection.
0734: ACCURATE LESION LOCALISATION AT COLONOSCOPY: AN ANAL-
YSIS OF POTENTIAL INFLUENCING FACTORS
A.S. Bryce*,1, S.J. Moug 2, M.S. Johnstone 1. 1University of Glasgow, Glasgow,
UK; 2Royal Alexandra Hospital, Paisley, UK.
Introduction: In this modern surgical era of laparoscopic resections and
cancer screening, the accuracy of colonoscopy for pre-operatively localising
colorectal tumours has taken on a new importance. This prospective study
aimed to elucidate factors which potentially inﬂuence this accuracy.
Methods: Patients who underwent surgical resection for a colorectal
tumour were recruited from ﬁve centres. To determine localisation accu-
racy, tumour location as reported by colonoscopy and radiological imaging
was compared with “true” (intra-operative) location. Also recorded were
patient and colonoscopic data.
Results: Tumour location at colonoscopy matched true location in 88 of
111 patients (79.3%). If patient BMI was  27.0 kg/m2 and if colonoscopy
was completed, colonoscopic localisation was more accurate (p<0.05).
Combination of eight bowel segments into three “super-segments”
revealed decreased localisation accuracy in tumours localised from sig-
moid colon to hepatic ﬂexure, in comparison to those localised to rectum,
and ascending colon to caecum (p<0.05).
Conclusions: This study adds information to a topic whose coverage
thus far has been sparse. The observations of increased likelihood of
inaccurate localisation (p<0.05) when colonoscopy is incomplete, patient
BMI is< 27.0 kg/m2, or a tumour is colonoscopically localised from sigmoid
colon to hepatic ﬂexure may be worth carrying forward to clinical practice.
0740: THE IMPACT OF INTRAVENOUS BUSCOPAN ON POLYP DETECTION
RATES AND PATIENT DISCOMFORT LEVELS DURING COLONOSCOPY
Qamar Zaman*,1, Aftab Khan 2, Daniel Thomas 1, Rajab Kerwat 1,
Hamid Khawaja 1, John Payne 1. 1Queen Mary Hospital, Sidcup, UK;
2University College London, London, UK.
Introduction: Hyoscine Butylbromide (Buscopan, Boehringer Ingelheim)
is sometimes administered intravenously during colonoscopy to relief
patients discomfort and/or improve diagnostic yield. In this study we
investigate the impact of intravenous Buscopan on polyp detection rates
and patient discomfort levels during colonoscopy.
Methods: We undertook a retrospective review of all colonoscopy reports
with completed data during the period January 2008 till June 2013 at our
institution. We compared the polyp detection rate and patient discomfort
levels with and without administration of intravenous Buscopan.
Results: A total of 7092 colonoscopieswereundertakenduring studyperiod.
Therewas F:M 1.25:1, median age 63 years (IQR 50-73). Buscopanwas given
to 30.1% of total patients and 90% of those received an average dose of 20mg.
Polyps were detected in 19.2% patients. The patient discomfort levels were
none¼52%, minimum¼10.2%, mild¼29.5% and moderate¼8.2%. On univar-
iate analysis, there was only modest statistical difference in polyp detection
rate (p0.057), but signiﬁcant inﬂuenceonpatient discomfort levels (p 0.004)
with additional use of Buscopan. Multivariate analysis showed signiﬁcant
improvement in polyp detection (0.007) and patient discomfort levels (p
<0.001) with addition of Buscopan during colonoscopy.
Conclusions: Buscopan is an important adjunct to improve polyp detec-
tion rates and patient discomfort levels during colonoscopies.
0770: AUDIT ON ELECTIVE COLORECTAL SURGERY IN THE ULSTER HOS-
PITAL
Dorothy Johnston*, Bill Campbell, Peter McGarrity, Jonathan McCarter,
Ian McAllister. Ulster Hospital, Dundonald, UK.
Introduction: To examine the outcomes of patients undergoing major
colorectal resections in thisunit as compared tooutcomes fromtheNational
Bowel Cancer Audit and the Association of Coloproctology guidelines.
Method: Data was gathered retrospectively with patients identiﬁed using
ICD-10 coding for major colorectal resections.
69 patients were identiﬁed over the time period of April to September
2013 and were followed up for 30 days post-operatively.
Complications were rated using the Clavien-Dindo scoring system.
Results: We found that of 39 males and 30 females 65% underwent open
resection and the remainder laparoscopic.
